Articles Referencing MDCI

Zacks.com

Reiterate Baxter at Neutral - Analyst Blog

On Apr 22, we reiterated Baxter International ( BAX ) at Neutral, based on the company's narrow beat of the Zacks Consensus Estimate for earnings. We also noted the company's maintenance of... Read >>

Zacks.com

Reiterate Intuitive at Neutral - Analyst Blog

On Apr 22, we retained Intuitive Surgical, Inc. ( ISRG ) at Neutral after the company reported favorable results for the first quarter 2013. In addition, ISRG made adjustments to its... Read >>

Zacks.com

New Bioinformatics Tools by LIFE - Analyst Blog

Life Technologies Corporation ( LIFE ) recently revealed a couple of new bioinformatics solutions. These offerings will work on the Oncomine platform, which was added to the company's... Read >>

Zacks.com

Quest Closes HemoCue Divestment - Analyst Blog

As per its plan to sell the HemoCue diagnostics products business, Quest Diagnostics ( DGX ), recently completed the divesture of the same. The company announced that Radiometer Medical ApS... Read >>

Zacks.com

CYBX Resumes Reimbursement Efforts - Analyst Blog

Cyberonics ( CYBX ) recently provided further information on its reimbursement claim submission to the Centers for Medicare & Medicaid Services (CMS). The leading player in the... Read >>

Zacks.com

Medtronic Remains at Neutral - Analyst Blog

We recently reinstated our Neutral recommendation on Medtronic, Inc. ( MDT ), a leading medical devices company. While we are to-some-extent relieved with the signs of stability in... Read >>

Zacks.com

Still Neutral on Merge Healthcare - Analyst Blog

On Apr 2, 2013, we reaffirmed our long-term Neutral recommendation on Merge Healthcare Incorporated ( MRGE ) as the company's bright growth prospects are to some extent dwarfed... Read >>

Zacks.com

Boston Scientific Stays at Neutral - Analyst Blog

We recently reinstated our Neutral recommendation on Boston Scientific Corporation ( BSX ), a leading medical devices company. After several quarters of weak performance, we are encouraged... Read >>

Zacks.com

LIFE Grows AmpliSeq Portfolio - Analyst Blog

Global biotechnology tools company - Life Technologies Corp ( LIFE ) continued the expansion of its Ion AmpliSeq portfolio with the recent launch of two Ion AmpliSeq Community Panel designs... Read >>

Zacks.com

FDA Clears Affinity, Boosts MDT's Biz - Analyst Blog

The recent US Food and Drug Administration ("FDA") 510(k) clearance for Affinity Fusion oxygenation system has enhanced the structural heart business of medical devices major - ... Read >>

Zacks.com

LH Expands Partnership with BMY - Analyst Blog

Laboratory Corporation of America Holdings ( LH ) recently expanded its long-term alliance with Bristol-Myers Squibb Company ( BMY ) by signing a new five-year agreement. Under this... Read >>

Zacks.com

CONMED Rolls Out Latest Innovations - Analyst Blog

Medical technologies and surgical devices company - CONMED Corporation ( CNMD ) introduced several new offerings at the 2013 American Academy of Orthopaedic Surgeons (AAOS) annual meeting... Read >>

Zacks.com

Patterson Buys Back Shares; Hikes Div - Analyst Blog

Patterson Companies Inc. ( PDCO ), a Minn.-based distributor of dental, veterinarian and rehabilitation medical supplies, recently announced a dividend hike as well as a share buyback... Read >>

Zacks.com

Safeway Upgraded to Outperform - Analyst Blog

On Mar 15, 2013, we upgraded Safeway Inc. ( SWY ) to Outperform following its robust results in the fourth quarter of 2012. With three consecutive positive earnings surprises and agreement... Read >>

Zacks.com

Patterson Reiterated at Neutral - Analyst Blog

On Mar 15, we retained Patterson Companies Inc. ( PDCO ) at Neutral, following its third-quarter fiscal 2013 results. Although results were in-line, the company needs to address its... Read >>

Displaying 1-15 of 51
<< first < previous 1 2 3 4 next > last >>